Sumitomo Pharma America Fellowships
Sumitomo Pharma America, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which will enhance the potential for accelerated career development. The following fellowship programs are currently offered by Sumitomo Pharma America in collaboration with MCPHS:.
- Scientific Communications/Medical Affairs
- Medical Information
- Regulatory Affairs (Not recruiting for 2023-2024)
Please see our brochure for additional details and feel free to review the content below.
Fellowship Overview
This fellowship program is designed to offer Doctor of Pharmacy graduates in-depth experience within a biopharmaceutical industry setting. In addition, PharmD graduates will have the opportunity to enhance their clinical and academic background in conjunction with MCPHS. Overall, this fellowship program will provide the training and experiences necessary to prepare the fellow for a career in the competitive pharmaceutical industry.
About Sumitomo Pharma America
Sumitomo Pharma America is a member of the Sumitomo Group, which has a history of approximately 400 years. We are a leading pharmaceutical company dedicated to discovering, developing, and commercializing therapeutic products that advance the science of medicine in the areas of psychiatry, neurology, and oncology to improve the lives of patients and their families.
Sumitomo Pharma America brings together scientific focus, pragmatism, and dedication to research with an entrepreneurial energy and willingness to take on any challenge, always keeping the longer view in sight. We will continue making active efforts for research and development of pharmaceuticals, regenerative medicine/cell therapy, and non-pharmaceutical products. Additionally, we will continue to work with national and international partners to keep a constant stream of new drugs flowing into the pipeline. At Sumitomo Pharma America, we strive to serve and create value for patients every day.